ESR1 and inflammatory breast carcinoma: Further, we proposed that miR-181b-5p, miR-200b-3p, miR-200c-3p, and miR-1-3p may have the potential to act as prognostic markers for IBC patients, given the relevance of ER and Her2 expression status.